Diseases [C] » Eye Diseases
Description
Diseases affecting the eye. MeSH
Hierarchy View
Subtype Terms (26)
Asthenopia
5 experimental drugs
Cogan Syndrome
3 approved drugs
Conjunctival Diseases
3 drugs (1 approved, 2 experimental)
Corneal Diseases
101 drugs (52 approved, 49 experimental)
Eye Abnormalities
1 experimental drug
Eye Diseases, Hereditary
31 drugs (17 approved, 14 experimental)
Eye Infections
11 drugs (8 approved, 3 experimental)
Eye Injuries
2 experimental drugs
Eyelid Diseases
8 drugs (7 approved, 1 experimental)
Eye Manifestations
1 approved drug
Eye Neoplasms
7 drugs (4 approved, 3 experimental)
Lacrimal Apparatus Diseases
14 drugs (7 approved, 7 experimental)
Lens Diseases
6 drugs (5 approved, 1 experimental)
Ocular Hypertension
91 drugs (36 approved, 55 experimental)
Ocular Motility Disorders
3 approved drugs
Optic Nerve Diseases
5 drugs (4 approved, 1 experimental)
Orbital Diseases
2 drugs (1 approved, 1 experimental)
Pupil Disorders
3 approved drugs
Refractive Errors
19 drugs (16 approved, 3 experimental)
Retinal Diseases
100 drugs (60 approved, 40 experimental)
Uveal Diseases
3 approved drugs
Vision Disorders
26 drugs (13 approved, 13 experimental)
Vitreous Detachment
9 drugs (8 approved, 1 experimental)
Phase 4 Indicated Drugs (14)
Phase 2 Indicated Drugs (9)
Other Experimental Indicated Drugs (19)
Organization Involved with Phase 4 Indications (51)
Organization Involved with Phase 3 Indications (51)
Abrams Eye Center, Cleveland, OH
Centre Hospitalier Intercommunal Creteil
Instituto Universitario de Oftalmobiología Aplicada
Mimetogen Pharmaceuticals USA, Inc.
National Center for Complementary and Integrative Health (NCCIH)
Organization Involved with Phase 2 Indications (56)
Organization Involved with Phase 1 Indications (11)
Organization Involved with Other Experimental Indications (21)
Hierarchy Tree View
UMLS Data
YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.